Lv71
5000 积分 2021-12-15 加入
Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma
1天前
待确认
Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases
11天前
已完结
Blockade of CD95/CD95L Death Signaling Enhances CAR T Cell Persistence and Antitumor Efficacy
28天前
已完结
Potentiating CAR-T bystander killing by enhanced Fas/FasL signaling mitigates antigen escape in heterogeneous tumors
28天前
已关闭
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction
1个月前
已完结
Preclinical Development of a Novel Humanized and Fc-Engineered Antibody-Drug Conjugate for the Therapy of T-Cell Acute Lymphoblastic Leukemia
1个月前
已关闭
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
1个月前
已完结
Engineering IgG antibodies for intracellular targeting and drug delivery
1个月前
已完结
Site-specific tethering nanobodies on recombinant adeno-associated virus vectors for retargeted gene therapy
1个月前
已完结
皖公网安备34019202002308
